Suppr超能文献

十年后:一家医院治疗 HIV/AIDS 相关恶性肿瘤的单中心经验

Ten years later: a single hospital experience with malignancy in HIV/AIDS.

机构信息

Division of Oncology, Bronx-Lebanon Hospital Center, Bronx, New York 10457, USA.

出版信息

J Surg Oncol. 2010 Sep 1;102(3):282-6. doi: 10.1002/jso.21590.

Abstract

BACKGROUND AND OBJECTIVE

We present our experience in the era of HAART with 5,112 patients having HIV infection or AIDS, treated between 2002 and 2006 in our hospital, 182 of whom had malignancies (3.56%). We compared our findings to those from a similar cohort of patients studied 10 years earlier.

METHODS

The charts were reviewed and data was electronically collected as in our 1993-1998 study. Similar statistical analyses were performed in both studies and the results were compared.

RESULTS

For the current study the average patient age increased by 9 years. A decrease in AIDS-defining cancers (ADC), from 63.6% to 37.3% and a higher incidence of non-AIDS-defining cancers (NADC), 62.7 as opposed to 37.9% was found. No decrease in the incidence of non-Hodgkin's B cell lymphoma (NHL) was noted. There was an increase in the number of opportunistic infections notably hepatitis C virus (HCV) and hepatitis B virus (HBV).

CONCLUSIONS

HIV/AIDS patients on HAART are older, have lower rates of AIDS related Kaposi's sarcoma and a higher incidence of NADCs than did patients in the early HAART era. No decrease in the proportion of NHL was observed.

摘要

背景与目的

我们展示了在高效抗逆转录病毒治疗(HAART)时代的经验,共有 5112 例 HIV 感染者或 AIDS 患者在我们医院接受治疗,其中 182 例(3.56%)患有恶性肿瘤。我们将我们的发现与 10 年前类似患者队列的研究结果进行了比较。

方法

回顾病历并电子收集数据,与我们 1993-1998 年的研究相同。在两项研究中均进行了类似的统计分析,并比较了结果。

结果

对于当前的研究,患者的平均年龄增加了 9 岁。艾滋病定义性癌症(ADC)的发病率从 63.6%下降至 37.3%,而非艾滋病定义性癌症(NADC)的发病率从 37.9%上升至 62.7%。非霍奇金 B 细胞淋巴瘤(NHL)的发病率没有下降。机会性感染的数量增加,特别是丙型肝炎病毒(HCV)和乙型肝炎病毒(HBV)。

结论

接受 HAART 的 HIV/AIDS 患者比早期 HAART 时代的患者年龄更大,艾滋病相关卡波西肉瘤的发病率更低,NADCs 的发病率更高。NHL 的比例没有下降。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验